CD105 expression is an independent predictor of survival in patients with endometrial cancer


Erdem O., Taskiran C., Onan M. A. , Erdem M., Guner H., Ataoglu O.

GYNECOLOGIC ONCOLOGY, cilt.103, sa.3, ss.1007-1011, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 103 Konu: 3
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.ygyno.2006.06.010
  • Dergi Adı: GYNECOLOGIC ONCOLOGY
  • Sayfa Sayıları: ss.1007-1011

Özet

Objective. The purpose of this study was to detect the prognostic value of CD105 (endoglin) and also to compare with CD34 and vascular endothelial growth factor (VEGF) in patients with endometrial adenocancer.